2160.HK

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Medical - Devices

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$314M	-32.3%	$-0.01	$-0.01–$-0.01	—	1
2027	$341M	+8.5%	$-0.00	$-0.00–$-0.00	—	1
2028	$809M	+137.2%	$0.00	$0.00–$0.00	—	0

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
2160.HKMicroPort CardioFlow Medtech Corporation	$1.28	+0.00%	$629M	—
1345.HKShanghai Pioneer Holding Ltd	$2.19	+0.00%	$2.5B	—
1696.HKSisram Medical Ltd	$2.04	+0.99%	$953M	—
2197.HKClover Biopharmaceuticals, Ltd.	$1.98	+0.77%	$2.6B	—
2235.HKMicroTech Medical (Hangzhou) Co., Ltd.	$6.83	+1.79%	$2.8B	—
2500.HKVenus Medtech (Hangzhou) Inc.	$1.14	+0.00%	$503M	—
2633.HKJacobson Pharma Corporation Limited	$0.96	-2.04%	$1.9B	—

Source: Financial Modeling Prep · peers by sector/industry

MicroPort CardioFlow Medtech Corporation

MicroPort CardioFlow Medtech Corporation is a medical technology firm dedicated to the comprehensive research, development, and commercialization of advanced transcatheter and surgical therapies for structural heart conditions. Operating primarily within the People's Republic of China, its innovative product line includes the Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set, specifically engineered to treat aortic, mitral, tricuspid, and surgical valve disorders. The company also supplies a range of essential procedural accessories. MicroPort CardioFlow Medtech, which commenced operations in 2010, maintains its corporate headquarters in Shanghai, China.

www.cardioflowmedtech.com

Employees: 1,415
IPO / List date: Feb 4, 2021
HQ: CN

Held by traders on TradeandTell

No one on the platform currently holds 2160.HK.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in 2160.HK as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded 2160.HK yet.